Rheumatoid Arthritis Diagnostic Tests Market,Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test, Monitoring RA Treatment Efficiency Tests ), By End User, By Region

Description

Rheumatoid Arthritis Diagnostic Tests Market is estimated to be valued at USD 3,255.4 Mn in 2026 and is expected to reach USD 4,767.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,255.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.60%	2033 Value Projection:	USD 4,767.1 Mn

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease, which means that your immune system attacks healthy cells in your body by mistake, causing inflammation (painful swelling) in the affected parts of the body. RA mainly attacks the joints, usually many joints at once. RA commonly affects joints in the hands, wrists, and knees. In a joint with RA, the lining of the joint becomes inflamed, causing damage to joint tissue. This tissue damage can cause long-lasting or chronic pain, unsteadiness (lack of balance), and deformity (misshapenness).RA can also affect other tissues throughout the body and cause problems in organs such as the lungs, heart, and eyes.Rheumatoid arthritis is an autoimmune condition, which means it's caused by the immune system attacking healthy body tissue. The rheumatoid arthritis diagnostic tests market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally.

Market Dynamics

The key market players are focusing on adoption of growth organic strategies such launching of diagnostic blood test for rheumatoid arthritis, which is attributed to the growth of global rheumatoid arthritis diagnostic tests market. For instance, in March 2020, BD (Becton, Dickinson and Company) is a medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to rhumetoid arthritis in as little as 15 minutes test has been clinically validated at several hospitals and clinical laboratories in both the U.S. and China.

Key features of the study:

This report provides an in-depth analysis of the global rheumatoid arthritis diagnostic tests market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2026-2033, considering 2025 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global rheumatoid arthritis diagnostic tests market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include include Abbott Diagnostics (Abbott Laboratories), Labcorp ,Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Augurex Life Sciences Corp., Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global rheumatoid arthritis diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market

Detailed Segmentation:

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Revenue, USD Mn, 2021 - 2033)
Serology Test
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
Monitoring RA Treatment Efficiency Tests
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
Global Rheumatoid Arthritis Diagnostic Tests Market, By End User (Revenue, USD Mn, 2021 - 2033)
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
Global Rheumatoid Arthritis Diagnostic Tests, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Abbott Diagnostics (Abbott Laboratories) *
Labcorp
Antibodies Inc.
Networks LLC
Beckman Coulter, Inc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare GmbH
Augurex Life Sciences Corp.
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Exagen Inc.
Genway Biotech, Inc.
Microdrop LLC (imaware)
Svar Life Science AB
Thermo Fisher Scientific Inc.

Product Code: CMI3716

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
Key Developments
PEST Analysis

4. Global Rheumatoid Arthritis Diagnostic Tests Market

Economic Impact
Impact on Supply and Demand

5. Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2021 €" 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Serology Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Segment Trends
  - Erythrocyte Sedimentation Rate (ESR)
  - Rheumatoid Factor (RF)
  - Anti-cyclic Citrullinated Peptide (anti-CCP)
  - Antinuclear Antibody (ANA)
  - Uric Acid
  - Other Tests
Monitoring RA Treatment Efficiency Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Segment Trends
Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test

6. Global Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2021 €" 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
Private Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
Public Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)

7. Global Rheumatoid Arthritis Diagnostic Tests Market, By Regions, 2021 €" 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Labcorp
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Antibodies Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Networks LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Beckman Coulter, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Euro Diagnostica AB, F.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hoffmann-La Roche Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Qiagen NV
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Siemens Healthcare GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Augurex Life Sciences Corp.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bio Rad Laboratories Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Exagen Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genway Biotech, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Microdrop LLC (imaware)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Svar Life Science AB
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

9. Section

References
Research Methodology
About us and Sales Contact